Cargando…
Rac1 is a novel therapeutic target in mantle cell lymphoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809391/ https://www.ncbi.nlm.nih.gov/pubmed/29434202 http://dx.doi.org/10.1038/s41408-018-0052-0 |
| _version_ | 1783299547195244544 |
|---|---|
| author | Tian, Tian Bi, Chengfeng Hein, Ashley L. Zhang, Xuan Wang, Cheng Shen, Songfei Yuan, Ji Greiner, Timothy C. Enke, Charles Vose, Julie Yan, Ying Fu, Kai |
| author_facet | Tian, Tian Bi, Chengfeng Hein, Ashley L. Zhang, Xuan Wang, Cheng Shen, Songfei Yuan, Ji Greiner, Timothy C. Enke, Charles Vose, Julie Yan, Ying Fu, Kai |
| author_sort | Tian, Tian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5809391 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58093912018-02-13 Rac1 is a novel therapeutic target in mantle cell lymphoma Tian, Tian Bi, Chengfeng Hein, Ashley L. Zhang, Xuan Wang, Cheng Shen, Songfei Yuan, Ji Greiner, Timothy C. Enke, Charles Vose, Julie Yan, Ying Fu, Kai Blood Cancer J Correspondence Nature Publishing Group UK 2018-02-12 /pmc/articles/PMC5809391/ /pubmed/29434202 http://dx.doi.org/10.1038/s41408-018-0052-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Tian, Tian Bi, Chengfeng Hein, Ashley L. Zhang, Xuan Wang, Cheng Shen, Songfei Yuan, Ji Greiner, Timothy C. Enke, Charles Vose, Julie Yan, Ying Fu, Kai Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title | Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title_full | Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title_fullStr | Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title_full_unstemmed | Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title_short | Rac1 is a novel therapeutic target in mantle cell lymphoma |
| title_sort | rac1 is a novel therapeutic target in mantle cell lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809391/ https://www.ncbi.nlm.nih.gov/pubmed/29434202 http://dx.doi.org/10.1038/s41408-018-0052-0 |
| work_keys_str_mv | AT tiantian rac1isanoveltherapeutictargetinmantlecelllymphoma AT bichengfeng rac1isanoveltherapeutictargetinmantlecelllymphoma AT heinashleyl rac1isanoveltherapeutictargetinmantlecelllymphoma AT zhangxuan rac1isanoveltherapeutictargetinmantlecelllymphoma AT wangcheng rac1isanoveltherapeutictargetinmantlecelllymphoma AT shensongfei rac1isanoveltherapeutictargetinmantlecelllymphoma AT yuanji rac1isanoveltherapeutictargetinmantlecelllymphoma AT greinertimothyc rac1isanoveltherapeutictargetinmantlecelllymphoma AT enkecharles rac1isanoveltherapeutictargetinmantlecelllymphoma AT vosejulie rac1isanoveltherapeutictargetinmantlecelllymphoma AT yanying rac1isanoveltherapeutictargetinmantlecelllymphoma AT fukai rac1isanoveltherapeutictargetinmantlecelllymphoma |